(Sharecast News) - Boston Scientific said on Monday that it has invested $1.5bn in privately-held MiRus in exchange for a 34% stake, with an exclusive option to buy the company's novel balloon-expandable aortic valve business.
MiRus is developing and commercialising proprietary biomaterials, implants and procedural solutions for the treatment of cardiovascular...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE